Diet Drug Report
DietDrugReport
 
Your INDEPENDENT source of news about prescription and over-the-counter diet drugs
 

 

  Weight-Loss Supplements: PatentLEAN
 

Expensive ads cleverly masquerading as newspaper stories are reporting soaring demand for a "newly approved diet pill," which closer examination reveals to be neither new nor a government-approved drug being marketed under the name PatentLEAN.

PatentLEAN is a so-called fat burner commonly referred to for short as 7-Keto (3-acetyl-7-oxo-dehydroepiandrosterone), a downstream metabolite of DHEA. Under various names, this active ingredient has been around for more than a decade. It is promoted as a weight loss aid for its supposed thermogenic effect.

Animal studies have demonstrated that 7-Keto can enhance thermogenesis, which may translate into weight loss. The theory behind this supplement is that DHEA levels decline as we age, and 7-Keto replaces declining DHEA, resulting in increases to an individual's metabolism.

According to the latest ads, which announce a "12 hour deadline" for readers to get "free pills approved in the ConsumerLab test featured on NBC, Today Show, CNN, and Oprah Magazine," two clinical studies showed that people taking PatentLEAN together with proper diet and exercise lost three times as much weight those who tried diet and exercise alone.

No information about these trials is provided either in the ads or on the website of PatentHEALTH, LLC, the promoter of PatentLEAN. Very sketchy information about the trials is provided at PatientLEAN.com. From what we have been able to determine, these short trials do not appear to have been well designed, and provide relatively weak support for the weight-loss claims.

Notwithstanding either the name, or the claims in the ad that PatentLEAN has "four U.S. patents pertaining to weight loss," we have found no evidence that any patents exist under the name PatentLEAN. The only patent number provided on the site, PatentLEAN.com, refers to a DHEA patent issued in 1992.

Our bottom line is when companies feel the need to try to fool newspaper readers into believing that they are reading a news story about a product, and not a paid ad, that's probably a flashing-signal for the warning: Buyer Beware.

Rimonabant Report

 

Other Diet Resources
Privacy Policy | Terms and Disclaimers | About the Diet Drug Report
Click to VerifyWe subscribe to the HONcode principles of the HON Foundation.
This is an independent news site reporting on prescription and over-the-counter diet drugs and on the more than 200 additional diet drugs currently in various stages of development. . Nothing on this site is intended to infringe on any trademarks. Nothing on this site is intended as medical advice. The information provided is for informational purposes only. Always consult a doctor or medical professional with questions regarding a medical condition.

Last Updated: 03/06/2008 Copyright 2004-2006 Medical Week News, Inc. All Rights Reserved